What question did this study set out to answer?

The aim is to evaluate the effectiveness and safety of low-dose, slow-escalation oral immunotherapy for walnut and cashew allergies in children.

April 21, 2026

Low‐Dose, Slow‐Escalation Home‐Based and Sustainable Oral Immunotherapy for Walnut and Cashew Allergy: A Retrospective Case Series

Key Points

The aim is to evaluate the effectiveness and safety of low-dose, slow-escalation oral immunotherapy for walnut and cashew allergies in children.
Retrospective case series design
Included children with walnut and cashew allergies
Monitored for tolerance and side effects during treatment
No cases of anaphylaxis reported during the treatment
Many children achieved clinical tolerance for unrestricted walnut and cashew intake

Abstract

Summary Box Low‐dose, slow‐escalation oral immunotherapy was well tolerated in children with walnut and cashew allergies. No anaphylaxis occurred, and many children achieved clinical tolerance for unrestricted daily walnut and cashew intake.

Low‐Dose, Slow‐Escalation Home‐Based and Sustainable Oral Immunotherapy for Walnut and Cashew Allergy: A Retrospective Case Series

Key Points

Abstract

Cite This Study

Also Consider

Also Consider